FDA Clearance Tracker · P210017
Cross-Seal Suture-Mediated Vascular Closure Device System
Last checked: Nov 20, 2026Latest source record: Sep 26, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 26, 2023
Approved
Time to decision
880 days
Received Apr 29, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P210017
- Device name
- Cross-Seal Suture-Mediated Vascular Closure Device System
- Applicant
- Terumo Medical Corporation
- Applicant location
- Somerset, NJ
- Received
- Apr 29, 2021
- Decided
- Sep 26, 2023
- Decision
- Approved
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the Cross-Seal Suture-Mediated Vascular Closure Device System. The device is indicated for the percutaneous delivery of sutures for closing the common femoral artery access site while reducing time-to-hemostasis in patients who have undergone diagnostic or interventional catheterization procedures using 8F to 18F sheaths. The Cross-Seal System is indicated for one access site per leg.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MGB. The earliest in FDA's data is P920004, decided Sep 29, 1995.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Terumo Medical Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MISAGO(TM) RX Self-expanding Peripheral StentPMA supplement
P140002-S032 · Decided Jul 16, 2026 · 199 days after receipt · Panel Track
Device type: STENT, ILIAC (NIO) · Cardiology
- R2P Navicross510(k)
K231044 · Decided Jul 27, 2023 · 106 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
K213531 · Decided Dec 20, 2021 · 45 days after receipt
Device type: Clamp, Vascular (DXC) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.